These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1655603

  • 1. [Measurement of serum immunoreactive beta-glucuronidase: a possible serological marker for histological hepatic cell necrosis and to predict the histological progression of hepatitis].
    Ohta H.
    Hokkaido Igaku Zasshi; 1991 Jul; 66(4):545-57. PubMed ID: 1655603
    [Abstract] [Full Text] [Related]

  • 2. [Measurement of human serum and liver tissue immunoreactive gamma-glutamyl transpeptidase in patients with various liver diseases].
    Yamada M.
    Hokkaido Igaku Zasshi; 1988 Jan; 63(1):44-55. PubMed ID: 2896151
    [Abstract] [Full Text] [Related]

  • 3. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T, Inuzuka S, Sata M, Koh H, Tamaki S, Kin M, Sugawara H, Sakata R, Torimura T, Tanikawa K.
    Hepatogastroenterology; 1995 Jan; 42(5):522-7. PubMed ID: 8751209
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S, Shiota G, Kawasaki H.
    Hepatogastroenterology; 2003 Jan; 50(53):1569-74. PubMed ID: 14571788
    [Abstract] [Full Text] [Related]

  • 5. Serum immunoreactive beta-glucuronidase determined by an enzyme-linked immunosorbent assay in patients with hepatic diseases.
    Ohta H, Ono M, Sekiya C, Namiki M.
    Clin Chim Acta; 1992 Jun 15; 208(1-2):9-21. PubMed ID: 1638757
    [Abstract] [Full Text] [Related]

  • 6. Elevated serum beta-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats.
    George J.
    Biochem Cell Biol; 2008 Jun 15; 86(3):235-43. PubMed ID: 18523484
    [Abstract] [Full Text] [Related]

  • 7. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
    Murawaki Y, Kusakabe Y, Hirayama C.
    Hepatology; 1991 Dec 15; 14(6):1167-73. PubMed ID: 1683640
    [Abstract] [Full Text] [Related]

  • 8. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS, Hong SI, Park SY, Son Y, Lee YS, Chung YH, Yang SK, Suh DJ, Min YI.
    Anticancer Res; 1995 Dec 15; 15(6B):2777-80. PubMed ID: 8669863
    [Abstract] [Full Text] [Related]

  • 9. Lysosomal enzymes in sera and granulocytes of patients with chronic liver diseases.
    Fehér J, Toncsev H, Fehér E, Kiss A, Vasady A.
    Int J Tissue React; 1981 Mar 15; 3(1):31-7. PubMed ID: 7287055
    [Abstract] [Full Text] [Related]

  • 10. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
    Zheng T, Ren ZY.
    Chin Med J (Engl); 1990 Sep 15; 103(9):729-34. PubMed ID: 2174763
    [Abstract] [Full Text] [Related]

  • 11. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M, Onuk MD, Akçay F, Savas MC.
    Hepatogastroenterology; 2002 Sep 15; 49(48):1645-8. PubMed ID: 12397754
    [Abstract] [Full Text] [Related]

  • 12. Serum xanthine oxidase in human liver disease.
    Battelli MG, Musiani S, Valgimigli M, Gramantieri L, Tomassoni F, Bolondi L, Stirpe F.
    Am J Gastroenterol; 2001 Apr 15; 96(4):1194-9. PubMed ID: 11316169
    [Abstract] [Full Text] [Related]

  • 13. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
    Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S.
    Hepatology; 1991 Jan 15; 13(1):1-5. PubMed ID: 1824837
    [Abstract] [Full Text] [Related]

  • 14. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults.
    Assy N, Minuk GY.
    Am J Gastroenterol; 2000 Jun 15; 95(6):1545-50. PubMed ID: 10894594
    [Abstract] [Full Text] [Related]

  • 15. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M.
    Fukuoka Igaku Zasshi; 1991 Jan 15; 82(1):21-30. PubMed ID: 1708742
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS.
    Princess Takamatsu Symp; 1995 Jan 15; 25():27-32. PubMed ID: 8875606
    [Abstract] [Full Text] [Related]

  • 17. Detection of fibronectin receptor in sera: its clinical significance as a parameter of hepatic fibrosis.
    Yamauchi M, Nakajima H, Ohata M, Hirakawa J, Mizuhara Y, Nakahara M, Kimura K, Fujisawa K, Kameda H.
    Hepatology; 1991 Aug 15; 14(2):244-50. PubMed ID: 1830562
    [Abstract] [Full Text] [Related]

  • 18. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
    Böker KH, Pehle B, Steinmetz C, Breitenstein K, Bahr M, Lichtinghagen R.
    Hepatogastroenterology; 2000 Aug 15; 47(33):812-9. PubMed ID: 10919037
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M, Andorno S, La Terra G, Boldorini R, Leone F, Pittau S, Zecchina G, Aglietta M, Saglio G.
    Ital J Gastroenterol Hepatol; 1998 Aug 15; 30(4):396-401. PubMed ID: 9789136
    [Abstract] [Full Text] [Related]

  • 20. The mechanism of the release of hepatic enzymes in various liver diseases. 1. Alterations in cytoplasmic and mitochondrial enzyme activities in serum.
    Miyake S.
    Acta Med Okayama; 1979 Aug 15; 33(4):287-304. PubMed ID: 227231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.